|
Century Therapeutics, Inc. (IPSC) DCF Avaliação
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Century Therapeutics, Inc. (IPSC) Bundle
Seja você um investidor ou analista, esta calculadora DCF (iPSC) é o seu recurso preferido para uma avaliação precisa. Apresentando dados reais da Century Therapeutics, Inc., você pode ajustar as previsões e observar instantaneamente os efeitos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | 5.2 | 2.2 | 1.9 | 1.6 | 1.4 | 1.2 | 1.0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | -57.01 | -14.25 | -14.25 | -14.25 | -14.25 | -14.25 |
| EBITDA | -19.8 | -51.4 | -89.9 | -119.3 | -121.2 | .4 | .3 | .3 | .2 | .2 |
| EBITDA, % | 100 | 100 | 100 | -2295.44 | -5423.18 | 20 | 20 | 20 | 20 | 20 |
| Depreciation | .2 | 1.8 | 4.6 | 10.1 | 13.0 | 1.9 | 1.6 | 1.4 | 1.2 | 1.0 |
| Depreciation, % | 100 | 100 | 100 | 193.71 | 583.62 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -20.0 | -53.2 | -94.5 | -129.4 | -134.3 | .4 | .3 | .3 | .2 | .2 |
| EBIT, % | 100 | 100 | 100 | -2489.15 | -6006.8 | 20 | 20 | 20 | 20 | 20 |
| Total Cash | 81.5 | 75.8 | 222.9 | 315.5 | 172.7 | 1.9 | 1.6 | 1.4 | 1.2 | 1.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .3 | .8 | .0 | 1.2 | 1.0 | .9 | .8 | .7 |
| Account Receivables, % | 100 | 100 | 100 | 15 | 0 | 63 | 63 | 63 | 63 | 63 |
| Inventories | 2.3 | 1.9 | -.3 | .0 | .0 | 1.1 | 1.0 | .8 | .7 | .6 |
| Inventories, % | 100 | 100 | 100 | 0 | 0 | 60 | 60 | 60 | 60 | 60 |
| Accounts Payable | 1.5 | 8.1 | 7.6 | 5.5 | 2.7 | 1.9 | 1.6 | 1.4 | 1.2 | 1.0 |
| Accounts Payable, % | 100 | 100 | 100 | 104.9 | 122.64 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -2.5 | -9.8 | -45.0 | -30.6 | -13.7 | -.8 | -.7 | -.6 | -.5 | -.4 |
| Capital Expenditure, % | 100 | 100 | 100 | -588.65 | -614.59 | -40 | -40 | -40 | -40 | -40 |
| Tax Rate, % | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 |
| EBITAT | -20.1 | -54.3 | -94.5 | -129.5 | -136.1 | .4 | .3 | .3 | .2 | .2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -23.1 | -55.4 | -133.5 | -153.0 | -138.8 | -1.6 | 1.4 | 1.2 | 1.0 | .9 |
| WACC, % | 7.77 | 7.77 | 7.77 | 7.77 | 7.77 | 7.77 | 7.77 | 7.77 | 7.77 | 7.77 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 1.9 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 1 | |||||||||
| Terminal Value | 15 | |||||||||
| Present Terminal Value | 11 | |||||||||
| Enterprise Value | 12 | |||||||||
| Net Debt | 1 | |||||||||
| Equity Value | 12 | |||||||||
| Diluted Shares Outstanding, MM | 59 | |||||||||
| Equity Value Per Share | 0.20 |
What You Will Get
- Editable Forecast Inputs: Effortlessly modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Century Therapeutics, Inc. (IPSC) financial data pre-loaded to enhance your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A sleek Excel model tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and optimizing your time.
Key Features
- Customizable Research Parameters: Adjust essential factors such as clinical trial success rates, market penetration, and R&D expenses.
- Instant Valuation Insights: Computes intrinsic value, net present value (NPV), and additional metrics in real-time.
- High-Precision Accuracy: Incorporates Century Therapeutics' actual financial data for credible valuation results.
- Streamlined Scenario Testing: Easily evaluate various assumptions and analyze different outcomes.
- Efficiency Booster: Remove the hassle of creating intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review Century Therapeutics, Inc.'s (IPSC) pre-filled financial data and forecasts.
- Step 3: Modify critical inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Watch the DCF model update instantly as you adjust your assumptions.
- Step 5: Analyze the outputs and leverage the results for your investment decisions.
Why Choose This Calculator for Century Therapeutics, Inc. (IPSC)?
- Designed for Experts: A sophisticated tool utilized by researchers, financial analysts, and biotech consultants.
- Accurate Data: Century Therapeutics’ historical and projected financials are preloaded for precision.
- Scenario Analysis: Effortlessly explore various forecasts and assumptions.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Comprehensive instructions lead you through each step of the process.
Who Should Use This Product?
- Individual Investors: Gain insights to make informed decisions regarding Century Therapeutics, Inc. (IPSC) stock.
- Financial Analysts: Enhance valuation processes with comprehensive financial models tailored for Century Therapeutics, Inc. (IPSC).
- Consultants: Provide clients with accurate and timely valuation insights related to Century Therapeutics, Inc. (IPSC).
- Business Owners: Learn from the valuation methods of innovative companies like Century Therapeutics, Inc. (IPSC) to inform your own business strategy.
- Finance Students: Explore valuation techniques through the lens of real-world data and scenarios involving Century Therapeutics, Inc. (IPSC).
What the Template Contains
- Historical Data: Includes Century Therapeutics, Inc.'s (IPSC) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Century Therapeutics, Inc.'s (IPSC) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Century Therapeutics, Inc.'s (IPSC) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.